Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof
US9925205B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Mar 6, 2014 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Mar 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/5021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to a composition comprising a multicationic drug and an organic multianion. In some embodiments, the multicationic drug is enclosed within a carrier. In some embodiments, the carrier is a liposome. In some embodiments, the multicationic drug and organic multianion are enclosed within a carrier, while in other embodiments, the multicationic drug is enclosed within the carrier and the organic multianion is outside the carrier. The present invention also relates, in part, to a method of treating a subject for pulmonary distress comprising administering to a subject in need thereof the aforementioned composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.